Group B streptococcal infection
-
To describe the situation, serotype distribution and some related factors of group B streptococcal infection during 35 – 37 weeks of pregnancy at Nghe An Maternity Hospital, 2018-2019.
15p gaocaolon7 18-09-2020 75 2 Download
-
Infection with Viridans Streptococci: Treatment Isolates from neutropenic patients with bacteremia are often resistant to penicillin; thus these patients should be treated presumptively with vancomycin until the results of susceptibility testing become available. Viridans streptococci isolated in other clinical settings usually are sensitive to penicillin. Abiotrophia Species (Nutritionally Variant Streptococci) Occasional isolates cultured from the blood of patients with endocarditis fail to grow when subcultured on solid media.
5p colgate_colgate 21-12-2010 88 4 Download
-
Group B Streptococcal Infection in Adults: Treatment GBS is less sensitive to penicillin than GAS, requiring somewhat higher doses. Adults with serious localized infections (pneumonia, pyelonephritis, abscess) should receive doses of ~12 million units of penicillin G daily; patients with endocarditis or meningitis should receive 18–24 million units per day in divided doses. Vancomycin is an acceptable alternative for penicillin-allergic patients.
5p colgate_colgate 21-12-2010 87 4 Download
-
Harrison's Internal Medicine Chapter 130. Streptococcal and Enterococcal Infections Streptococcal and Enterococcal Infections: Introduction Many varieties of streptococci are found as part of the normal flora colonizing the human respiratory, gastrointestinal, and genitourinary tracts. Several species are important causes of human disease. Group A Streptococcus (GAS, S.
5p colgate_colgate 21-12-2010 98 5 Download
-
Organism-Specific Therapies Streptococci To select the optimal therapy for streptococcal endocarditis, the minimum inhibitory concentration (MIC) of penicillin for the causative isolate must be determined (Table 118-4). The 2-week penicillin/gentamicin or ceftriaxone/gentamicin regimens should not be used to treat complicated native valve infection or prosthetic valve endocarditis. The regimen recommended for relatively penicillin-resistant streptococci is advocated for treatment of endocarditis caused by organisms of group B, C, or G.
5p thanhongan 07-12-2010 78 2 Download